Insightful analysis and commentary for the US and global equity investor
Contributors: Douglas McIntyre Jon C. Ogg

Previous Posts

Monday, October 23, 2006

Pre-Market Stock News (Oct. 23, 2006)

(A) Agilent Technologies could become more attractive according to Barron's articles.
(ALDN) Aladdin Knowledge Systems $0.26 non-GAAP EPS vs $0.23e.
(AMT) American Tower will refile an annual report to adjust for option grants.
(ARBX) Arbinet forms a committee to evaluate strategic alternatives.
(ASTE) Astec $0.46 EPS vs $0.42e.
(BJCT) Bioject Medical Tech CEO is retiring.
(BKS) Barnes & Noble may attract suitors according to Barron's.
(BOH) Bank of Hawaii $0.93 EPS vs $0.92e.
(DEO) Diagio positive on Cramer's MAD MONEY on Friday.
(EAC) Encore Acquisition lowered gas production targets for the quarter.
(ECIL) ECI Telecom plans an IPO for its Veraz Networks.
(ESLT) Elbit Systems gets a $19 million pact from Boeing.
(ETH) Ethan Allen $0.53 EPS vs $0.54e.
(F) Ford put Q3 earnings at $262 million but its real net loss is -$3.08 EPS; will restate earnings from 2001 to 2006 for hedging and derivative activities.; stock trading down over 1%.
(FLML) Flamel received FDA approval along with GlaxoSmithkline for blood pressure, heart attack, and heart failure.
(HAL) Halliburton $0.58 EPS vs $0.54e.
(HAS) Hasbro $0.58 EPS vs $0.50e.
(HEII) HEI Inc. CEO has resigned.
(HNAB) Hana Bio filed to sell $100 million in securities.
(IINT) Indus International is merging with MDSI in a private equity transaction at $3.85 per share.
(ISPH) Inspire Pharmaceuticals gets SEC Wells Notice.ic signed a Hasbro license pact.
(JNY) Jones Apparel received positive Barron's article.
(MNST) Monster Worldwide traded up 2% after Cramer said Yahoo! should acquire it.
(MSFT) Microsoft may need to acquire growth in the online operations according to WSJ.
(MSLV) MetaSolv Software being acquired by Oracle for $4.10 per share.
(NOK) Nokia may get more attractive according to Barron's.
(NHWK) Nighthawk Radiology $0.21 EPS vs $0.17e.
(NWRE) Neoware lowered revenue guidance to $21.5 million versus street estimates of almost $26 million.
(PQE) PetroQuestsells its business solutions segment to Snap-On for $500 million.
(RDYN) Replidyne and Forest Labs get a non-approvable letter from teh FDA for Faropenem as an oral antibiotic for respiratory treatment; FDA recommends more studies; company said it will be an additional 2 years.
(SAP) SAP wasn't really losing business to Oracle according to Barron's.
(SEPR) Sepracor said its Brovana inhalation solution showed positive results.
(SLAB) Silicon Labs $0.26 EPS vs $0.23e.
(SNA) Snap-On $0.48 EPS vs $0.44e, making a $500 million buy.
(SOMX) Somaxon reports positive Phase III insomnia data.
(SVU) SuperValu filed to sell $500 million in debt instruments.
(T) AT&T $0.63 EPS vs $0.58e.
(TRB) Tribune has alot of private equity interest according to WSJ.
(WMT) Wal-Mart has its analyst meeting starting today.
(XRX) Xerox $0.23 EPS vs $0.22e.

Powered by Blogger